Ultime notizie per Bunge Global (NYSE:BG) Azioni

Bunge Global

Bunge

Bunge Global SA formerly Bunge Ltd is an agribusiness and food company with operations along the farm-to-consumer food chain. The company segments include Agribusiness; Refined and Specialty Oils; Milling; Sugar and Bioenergy and Corporate and Other. It generates maximum revenue from the Agribusiness segment. The company is an oilseed processor and producer of vegetable oils and protein meals, based on processing capacity, a grain processor, the seller of packaged plant-based oils, producer and seller of wheat flour, bakery mixes, and corn-based products in North and South America.

Bunge Global SA

EFG HLDG SPONSORED 144A GDR

Biotech Group Acquisition Corp

BIONEUTRA GLOBAL CORP by BioNeutra Global Corporation

BioNeutra Global Corp

Pace Metals Ltd

PROXIMUS SA DE DROIT PUB by Proximus Group

Proximus SA

PROXIMUS ORD

PROXIMUS GROUP UNSP/ADR by Proximus Group

BRAVADA GOLD CORP NEW by Bravada Gold Corp.

Bravada Gold Corp

Blackstone Strategic Credit 2027 Term Fund Common Shares of Beneficial Interest

Blackstone Strategic Credit Fund

BGC Group Inc

BAILLIE GIFFORD CH GRTH by BAILLIE GIFFORD CHINA GROWTH TR PLC

BEGA CHEESE LTD UNSP/ADR by Bega Cheese Ltd

Bega Cheese Ltd

BARTON GOLD HLDGS LTD by Barton Gold Holdings Limited

Barton Gold Holdings Ltd

BLUE GEM ENTERPRISE by Blue Gem Enterprise

Blue Gem Enterprise

BEAUCE GOLD FIELDS INC by BEAUCE GOLD FIELDS INC.

Beauce Gold Fields Inc

Big 5 Sporting Goods Corporation - Common Stock

Big 5 Sporting Goods Corp

BILL IDENTITY LTD by BILL IDENTITY LTD

Barings Global Short Duration High Yield Fund Common Shares of Beneficial Interests

Barings Global Short Duration High Yield Fund

Birks Group Inc

Biolog-id

ETF Series Solutions Bahl & Gaynor Income Growth ETF

BGI INC by BGI, Inc.

BAILLIE GIFFORD JAPAN TR by Baillie Gifford Japan Trust Plc. (The)

BANGKOK BK PLC UTS by Bangkok Bank Public Co Ltd.

Bangkok Bank PCL

BioGaia AB

BioNexus Gene Lab Corp

FT Vest Gold Strategy Quarterly Buffer ETF

BLACKSTONE LN FINANCING by BLACKSTONE LN FINANCING LTD

BGM Group Ltd

BG Medicine Inc

BERGAMO AQUISITION CORP by Bergamo Acquisition Corp.

BeiGene, Ltd. - American Depositary Shares

BeiGene Ltd

BEIGENE ADS REP ORD

Banca Generali

Blackgold Natural Resources PLC

BIO-GENEX LABS INC by BIO-Genex Laboratories Inc.

Bango PLC

BANG & OULFSEN B ORD by Bang & Olufsen AS

Bang & Olufsen AS

CRAFT 1861 Global Holdings Inc Warrants (01/05/2026)

CRAFT 1861 Global Holdings Inc

BTS Group AB

CRAFT 1861 GLBL HLDGS INC by CRAFT 1861 Global Holdings Inc.

BlackRock Energy & Resources Trust

TONY G CO-INVT HLDGS LTD by TONY G CO-INVT HLDGS LTD.

Tony G Co-Investment Holdings Ltd

iShares USD Green Bond ETF

iShares Large Cap Growth Active ETF

BLUESTEM GROUP INC by Bluestem Group Inc.

Bluestem Group Inc

B&G Foods Inc

BGSF Inc

SHIN NIPPON PLC BAILLE by Shin Nippon Plc Baille Gifford

BW OFFSHORE ORD

Build Acquisition Corp Warrants (01/01/9999)

Blackrock Floating Rate Income Trust

BIGtoken Inc

GOAT Industries Ltd

BRISTOL GATE CONCNTRT US EQY UNT ETF

Benguet Corp

Blackstone Long Short Credit Income Fund Common Shares

Blackstone Long-Short Credit Income Fund

BRIGHT GREEN CORP by Bright Green Corporation

Bright Green Corp

Blackrock Enhanced International Dividend Trust

BUNGE GLOBAL ORD

Bunge Limited reports strong Q3 earnings of $2.29 per share, exceeding expectations. Results declined from the prior year due to the current global margin environment.
Bunge Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) reported third-quarter adjusted earnings per share of $2.29, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/b41619421/bunge-reports-third-quarter-2024-results" rel="noreferrer noopener">beating the street view of $2.14</a>. Quarterly sales of $12.908 billion outpaced the analyst consensus estimate of $12.774 billion.
Bunge Global said it reported solid performances in Agribusiness and Refined and Specialty Oils; however, results declined from the prior year due to the current global margin environment.
Net sales at Agribusiness decreased to $9.292 billion from $10.082 billion. The unit&#8217;s EBIT&nbsp;included a $19 million impairment charge in Income (loss) from affiliates related to a minority investment in North America.
The company continued to advance its Viterra integration planning and other growth priorities, including the successful closure of the sale of its sugar and bioenergy joint venture.
Also Read:<a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41622207/eli-lilly-q3-earnings-mounjaro-sales-more-than-double-takes-2-98-billion-hit-to-profit-cuts-annua" rel="noreferrer noopener"> Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks</a>
In the nine months ended September 30, cash provided by operations was $847 million, down from $1.860 billion in the same period last year. This reduction was primarily driven by lower reported net income.
Bunge exited the quarter with cash and equivalents worth $2.836 billion. Total inventories totaled $7.465 billion.
As of the quarter-end, the company&#8217;s long-term debt pegged at $4.777 billion.
Outlook: Bunge now expects FY24 adjusted EPS outlook of at least $9.25 (prior view: approximately&nbsp;$9.25), compared to an estimate of $9.41. In Agribusiness, results are expected to be slightly higher than in the previous quarter but lower than last year.
Additionally, the company currently anticipates an adjusted annual effective tax rate of 22% to 24%, net interest expense between $285 million and $305 million, capital expenditures in the upper range of $1.2 billion to $1.4 billion, and depreciation and amortization of approximately $450 million for 2024.
Price Action: BG shares are trading higher by 1.20% to $88.90 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41609022/openai-chooses-broadcom-for-ai-interface-chip-development" target="_blank" rel="noreferrer noopener">OpenAI Chooses Broadcom For AI Interface Chip Development</a></li>
</ul>

Earnings

Equities

News

Guidance

Markets

Movers

General

Bunge Beats On Q3 Earnings, Agribusiness Weighs On Growth Amid Global Margin Pressure

Bunge CEO Greg Heckman Says Expects To Close Viterra Acquisition Deal Later This Year Or In Early 2025; Says Has Received Conditional Clearance For Viterra Deal From European Commission

In Agribusiness, full-year results are forecasted to be up slightly from our previous outlook, reflecting the better than expected third quarter, but down compared to last year.
In Refined and Specialty Oils, full-year results are expected to be up from our previous outlook, but down compared to last year's record performance.
In Milling, full-year results are expected to be down from our previous outlook reflecting the lower than expected third quarter, but up from last year.
In Corporate and Other, full-year results are expected to be similar to our previous outlook.
In Non-Core, full-year results are expected to be down considerably from our previous outlook due to the lower than expected third quarter and the loss of income from the sale of our ownership in the joint venture, which closed on October 1, 2024.
Additionally, the Company currently expects the following for 2024: an adjusted annual effective tax rate range of 22% to 24%; net interest expense in the range of $285 to $305 million; capital expenditures in the upper end of the range of $1.2 to $1.4 billion; and depreciation and amortization of approximately $450 million.

Bunge Reiterates FY24 Adjusted EPS Outlook Of At Least $9.25 Vs. $9.41 Estimate; In Agribusiness Results Are Forecasted To Be Up Slightly But Down Compared To Last Year

Bunge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) reported quarterly earnings of $2.29 per share which beat the analyst consensus estimate of $2.14 by 7.01 percent. The company reported quarterly sales of $12.908 billion which beat the analyst consensus estimate of $12.774 billion by 1.05 percent. This is a 9.27 percent decrease over sales of $14.227 billion the same period last year.

Earnings Beats

Bunge Q3 2024 Adj. EPS $2.29 Beats $2.14 Estimate, Sales $12.908B Beat $12.774B Estimate

Bunge intends to use the net proceeds from the offering of the Senior Notes to fund a portion of the cash consideration for Bunge&#39;s proposed acquisition (the &quot;Business Combination&quot;) of Viterra Limited (&quot;Viterra&quot;) and to repay a portion of certain Viterra debt to be assumed in connection with the Business Combination, including, in each case, related fees and expenses, and, with any remaining amounts, for general corporate purposes.
Three tranches of senior unsecured notes (collectively, the &quot;Senior Notes&quot;), as follows:
<ul>
<li>$400 million&nbsp;aggregate principal amount of&nbsp;4.100%&nbsp;Senior Notes due 2028;</li>
<li>$800 million&nbsp;aggregate principal amount of&nbsp;4.200%&nbsp;Senior Notes due 2029; and</li>
<li>$800 million&nbsp;aggregate principal amount of&nbsp;4.650%&nbsp;Senior Notes due 2034.</li>
</ul>

Reported Earlier, Bunge Global Prices $2B Senior Notes Offering To Support Viterra Acquisition And Debt Repayment

WIIM

AGRI

BRLS

ELAB

NUZE

REBN

SANW

SISI

TBBB

UPXI

Vintage Wine Estates, Inc. - Common Stock

Shares of companies within the broader consumer staples sector are trading lower amid overall market weakness following weak US data. Soft guidance from Amazon may be negatively impacting the sector.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Morgan Stanley analyst Nigel Dally downgraded the rating for Voya Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOYA#NYSE">VOYA</a>) from Overweight to Equal-Weight, while cutting the price target from $79 to $76. Voya Financial shares fell 2.1% to close at $72.73 on Wednesday. <a href="https://www.benzinga.com/quote/VOYA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer analyst Jason Helfstein downgraded the rating for Etsy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>) from Outperform to Perform. Etsy shares gained 1% to settle at $65.14 on Wednesday. <a href="https://www.benzinga.com/quote/ETSY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Thomas Palmer downgraded Bunge Global SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) from Buy to Neutral, while cutting the price target from $125 to $114. Bunge Global shares fell 8.1% to close at $105.23 on Wednesday. <a href="https://www.benzinga.com/quote/BG/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point analyst Floris Van Dijkum downgraded the rating for Host Hotels &amp; Resorts, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) from Buy to Neutral, while lowering the price target from $25 to $18. Host Hotels shares fell 1.6% to close at $17.51 on Wednesday. <a href="https://www.benzinga.com/quote/HST/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Ki Bin Kim downgraded Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) from Buy to Hold and maintained the price target of $306. Public Storage shares fell 2.8% to settle at $295.92 on Wednesday. <a href="https://www.benzinga.com/quote/PSA/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40092288/nasdaq-settles-higher-as-nvidia-records-best-session-since-february-fear-greed-index-now-in-neutral">Nasdaq Settles Higher As Nvidia Records Best Session Since February: Fear &amp; Greed Index Now In &#8216;Neutral&#8217; Zone As Investor Sentiment Improves</a></li>
</ul>

Downgrades

Analyst Ratings

Trading Ideas

ETSY

VOYA

This Etsy Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Citigroup analyst Thomas Palmer downgrades Bunge Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) from Buy to Neutral and lowers the price target from $125 to $114.

Price Target

Citigroup Downgrades Bunge Global to Neutral, Lowers Price Target to $114

Bunge Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) shares are trading lower <a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener">after releasing results for the second quarter.</a>
The company reported adjusted earnings per share of $1.73, missing the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b40061621/bunge-reports-second-quarter-2024-results" rel="noreferrer noopener">analyst consensus of $1.80</a>. Second-quarter sales of $13.24 billion <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the street view of $14.27 billion.</a>
Bunge&#8217;s second-quarter results showed lower Agribusiness performance due to a more balanced global supply environment.
While Refined and Specialty Oils performed well, results were down compared to a strong previous year, it said in a press release.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/24/07/40062747/asia-markets-up-europe-opens-higher-crude-advances-2-6-global-markets-today-while-us-slept" rel="noreferrer noopener">Asia Markets Up, Europe Opens Higher, Crude Advances 2.6% &#8211; Global Markets Today While US Slept</a>
The company added that it made &#8220;excellent progress&#8221; on Viterra integration planning and other strategic priorities, including the announced sale of its interest in the sugar and bioenergy joint venture.
Greg Heckman, Bunge&#8217;s Chief Executive Officer, commented, &#8220;Our team delivered solid results for the second quarter while also moving forward on a range of strategic priorities, including announcing the sale of our interest in the BP Bunge Bioenergia joint venture.&#8221;
Cash used for operations in the six months ended June was $480 million compared to cash provided of $472 million in the same period last year.
The reduction of cash from operations was primarily driven by lower reported net income and net changes in working capital.&nbsp;
Bunge exited the quarter with cash and equivalents worth $1.161 billion. Total inventories totaled $8.057 billion.
As of the quarter-end, the company&#8217;s long-term debt pegged at $4.086 billion.
&#8220;Current market conditions have improved in some regions, but we continue to have limited visibility into the latter part of the year,&#8221;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener"> Heckman added.</a>
Outlook Raised: Bunge added that taking into account first-half results, the current margin environment, and forward curves, the company sees full-year 2024 adjusted EPS of approximately $9.25 versus the $9.46 estimate <a target="_blank" href="https://www.benzinga.com//node/38398262" rel="noreferrer noopener">(prior view: $9).</a>
Price Action: BG shares are trading lower by 6.61% to $106.98 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/07/40061267/asml-shares-surge-over-7-as-team-biden-plans-to-exempt-allies-from-new-rule-on-foreign-chip-equipmen" target="_blank" rel="noreferrer noopener">ASML Shares Surge Over 7% As Team Biden Plans To Exempt Allies From New Rule On Foreign Chip Equipment Export To China</a></li>
</ul>

Bunge Shares Tumble Over 6% After Q2 Miss; CEO Highlights Strategic Moves Amid Cash Flow Concerns

Bunge CFO Predicts 50% Drop In Capex For 2026 Compared To 2025, Excluding Viterra Merger

Bunge shares are trading lower following worse-than-expected Q2 financial results.

Bunge (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) reported quarterly earnings of $1.73 per share which missed the analyst consensus estimate of $1.80 by 3.89 percent. This is a 53.49 percent decrease over earnings of $3.72 per share from the same period last year. The company reported quarterly sales of $13.241 billion which missed the analyst consensus estimate of $14.273 billion by 7.23 percent. This is a 12.01 percent decrease over sales of $15.049 billion the same period last year.

Earnings Misses

CORRECTION: Bunge Q2 2024 Adj. EPS $1.73 Misses $1.80 Estimate, Sales $13.241B Miss $14.273B Estimate

Bunge Sees FY24 Adj EPS Of $9.25 Vs. $9.46 Est.

Bunge And Glencore-Backed Viterra Offered To Divest Assets In Two European Countries To Address EU Antitrust Concerns About $34B Deal

Shares of Bunge are trading lower following a report suggesting the company's $8 billion deal for Viterra is at risk of facing delays.

Bunge's $8B Deal For Viterra Said To Face Risk Of Delays

BP p.l.c. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) shares are trading lower after the company disclosed the trading update for the second quarter of FY24, with oil trading results expected to be weak after a strong first <a target="_blank" href="https://otp.investis.com/clients/uk/bp_plc/rns/regulatory-story.aspx?cid=233&amp;newsid=1840413" rel="noreferrer noopener">quarter</a>.
In the oil production and operations segment, the company anticipates realizations to have a favorable impact of $0.1 billion-$0.3 billion versus the first quarter, factoring in the effects of price lags on production in the Gulf of Mexico and the UAE.
The British oil giant expects Upstream production in the quarter to remain flat compared to the prior quarter, with stable oil production and a slight decrease in gas and low-carbon energy output.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39519449/is-bp-bailing-on-green-reportedly-shifts-gears-from-renewables-to-oil-and-gas" rel="noreferrer noopener">Is BP Bailing on Green? Reportedly Shifts Gears From Renewables To Oil And Gas</a>
In the gas and low-carbon energy segment, the company projects realizations to have an adverse impact of about $0.1 billion vs the prior quarter, including declines in non-Henry Hub natural gas prices.
Also, the gas marketing and trading result is expected to be average in the second quarter following a strong first quarter.
BP projects lower refining margins to negatively impact to have a negative impact of $0.5 billion-$0.7 billion owing to weaker middle distillate margins and narrower North American heavy crude oil differentials, along with increased turnaround activity.
Apart from this, the company disclosed that second-quarter results are expected to include post-tax adverse adjustments of $1.0 billion-$2.0 billion on asset impairments and onerous contract provisions, including charges related to the Gelsenkirchen refinery review.
Last month, BP agreed to&nbsp;purchase&nbsp;Bunge Global SA&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) 50% stake in their joint venture, BP Bunge Bioenergia S.A., for an enterprise <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39416447/bp-doubles-down-on-biofuels-buys-out-bunge-bioenergia-for-1-4b" rel="noreferrer noopener">value of about $1.4 billion</a>.
Related: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39452342/bp-eyes-biofuel-dominance-in-brazil-with-expansion-plans-report" rel="noreferrer noopener">BP Eyes Biofuel Dominance In Brazil With Expansion Plans: Report</a>
Investors can gain exposure to the stock via&nbsp;Direxion Hydrogen ETF&nbsp;(ARCA:&nbsp;HJEN)&nbsp;and&nbsp;First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA:&nbsp;EIPX).
Price Action: BP shares are down 3.99% at $35.08 premarket at the last check Tuesday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39650263/shell-totalenergies-bp-mitsui-join-adnocs-mega-lng-project-report" target="_blank" rel="noreferrer noopener">Shell, TotalEnergies, BP, Mitsui Join ADNOC&#8217;s Mega LNG Project: Report</a></li>
</ul>

Large Cap

BP Stumbles: Weak Oil Trading, Refining Margins Drag Down Q2 Outlook

Legal

SA's Competition Tribunal Approved Proposed Merger Wherein Bunge Global Sa Intends To Acquire Viterra Limited With Condition

BP p.l.c.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) reportedly plans to assess expanding and diversifying its biofuel operations in Brazil, exploring new products like second-generation ethanol and sustainable aviation fuel following its <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39416447/bp-doubles-down-on-biofuels-buys-out-bunge-bioenergia-for-1-4b" rel="noreferrer noopener">acquisition of a stake in BP Bunge Bioenergia</a>.
Last week, the British oil major bought Bunge Global SA‘s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) 50% stake in their joint venture, BP Bunge Bioenergia S.A., for an enterprise value of about $1.4 billion.
The acquisition will consolidate 100% of the venture's financial results, including net debt of about $0.5 billion and lease obligations of around $0.7 billion.
In written comments, the company expressed its plans to utilize the expansive biofuel infrastructure of the venture in Brazil, including an industrial complex comprising 11 plants located across five states that specialize in processing sugarcane, reported Reuters.
BP said in the comment, &#8220;We will seek to explore new growth opportunities in the region and develop new bioenergy platforms, such as next-generation ethanol, SAF, e-fuels and biogas,&#8221; per the report.
Biofuels expert Soren Jansen, a former executive at Brazil&#8217;s Copersucar, stated, &#8220;The whole alcohol-to-jetfuel supply chain is very expensive to build up, and the deep pockets from the oil companies is accelerating the process with an initial geographic spread over Brazil, the U.S., Europe and Japan.&#8221;
As per the report, the approach of BP mirrors that of Shell plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>), which previously teamed up with Brazilian sugar and ethanol major Cosan S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSAN#NYSE">CSAN</a>) to form Raizen SA, which is pioneering the world&#8217;s largest cellulosic ethanol program, focusing on second-generation ethanol.
Notably, Raizen launched its second 2G ethanol plant in May, producing fuel from biomass residues of processed sugarcane with 80% less carbon than gasoline.
Investors can gain exposure to the stock via&nbsp;Direxion Hydrogen ETF&nbsp;(ARCA:&nbsp;HJEN)&nbsp;and&nbsp;First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA:&nbsp;EIPX).
Price Action: BP shares are up 0.76% at $35.78 premarket at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Media

CSAN

SHEL

BP Eyes Biofuel Dominance In Brazil With Expansion Plans: Report

BP p.l.c.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) shares are trading higher after the company agreed to <a target="_blank" href="https://www.bp.com/content/dam/bp/business-sites/en/global/corporate/pdfs/news-and-insights/press-releases/bp-to-acquire-full-ownership-of-bp-bunge-bioenergia-while-refocusing-plans-for-new-biofuels-projects.pdf" rel="noreferrer noopener">purchase </a>Bunge Global SA&#8216;s&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BG#NYSE">BG</a>) 50% stake in their joint venture, BP Bunge Bioenergia S.A., for an enterprise value of about $1.4 billion.
The acquisition will consolidate 100% of the venture&#8217;s financial results, including net debt of about $0.5 billion and lease obligations of around $0.7 billion.
The buyout meets BP&#8217;s expected bioenergy returns threshold of over 15% and fits within its disciplined financial framework, which includes capital expenditure targets of around $16 billion for 2024 and 2025.
Upon completion, BP can produce about 50,000 barrels per day of ethanol equivalent from sugarcane through Bunge Bioenergia&#8217;s 11 agro-industrial units in five Brazilian states.
After the deal closes, BP will become the sole owner of the industrial-scale sugarcane and ethanol business.
This acquisition and focus on key biofuels projects are expected to support BP&#8217;s strategic growth in bioenergy, aiming for around $2 billion in EBITDA from bioenergy and $3 billion-$4 billion across all transition growth engines by 2025.
Bunge&nbsp;expects this second and final monetization event of its ownership in the business to yield <a target="_blank" href="https://www.benzinga.com//node/39408426" rel="noreferrer noopener">net proceeds close to&nbsp;$800 million.</a>
Emma Delaney, BP&#8217;s executive vice president, customers and products said, &#8220;Focusing our plans to develop new biofuels projects is also driven by value. Taken together, these changes can enable us to deliver the growth and returns we expect from biofuels, but in a simpler, more focused way. This is fully in line with bp&#8217;s priorities of driving focus into the business and growing shareholder returns.&#8221;
By 2025, BP aims to increase its biofuels production to approximately 50 million barrels per day (mbd) and its biogas supply to about 40 thousand <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">barrels of oil equivalent per day (mboed)</a>.
By 2030, the company targets to expand its biofuels production to around 100 mbd and its biogas supply to about 70 mboed.
As of first-quarter FY24-end, the company&#8217;s <a target="_blank" href="https://www.benzinga.com/news/earnings/24/05/38665532/why-bp-shares-are-trading-lower-premarket-today" rel="noreferrer noopener">net debt stood at&nbsp;$24.02 billion</a>.
Investors can gain exposure to the stock via&nbsp;Direxion Hydrogen ETF&nbsp;(ARCA:&nbsp;HJEN)&nbsp;and&nbsp;First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA:&nbsp;EIPX).
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/06/39247864/bp-tightens-workplace-relationship-rules-after-ceo-firing-report" rel="noreferrer noopener">BP Tightens Workplace Relationship Rules After CEO Firing: Report</a>
Price Action: BP shares are up 0.79% at $35.67 at the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

BP Doubles Down On Biofuels: Buys Out Bunge Bioenergia for $1.4B

Morgan Stanley analyst Steven Haynes maintained a Hold rating on Bunge Global (BG – Research Report) today and set a price target of $90.00. The co...

Morgan Stanley Sticks to Its Hold Rating for Bunge Global (BG)

Bunge Q3 2024 Earnings Preview

Here's the major earnings before the open tomorrow

Bunge Non-GAAP EPS of $2.29 beats by $0.14, revenue of $12.91B misses by $290M

Reports Q3 revenue $12.91B, consensus $12.77B. Greg Heckman, Bunge's (BG) Chief Executive Officer, commented, "Our team delivered a strong third qu...

Bunge reports Q3 adjusted EPS $2.29, consensus $2.15

Bunge Global SA 2024 Q3 - Results - Earnings Call Presentation

Bunge Global (BG) Q3 2024 Earnings Call Transcript

Bunge sees Viterra deal closing delayed into 2025

IVV: S&P 500 Dashboard For November

Salvator Tiano, an analyst from Bank of America Securities, reiterated the Buy rating on Bunge Global (BG – Research Report). The associated price ...

Comments

Bunge Global

Notizie

Ultime notizie per Bunge Global (NYSE:BG) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO